APC and ovarian carcinoma: The cisplatin-resistant ovarian cancer cell line A2780-DDP, developed for our investigation, demonstrated a decrease in β-catenin within the cytoplasm but an increase in its phosphorylated form in the nucleus, alongside a reduction in APC.